Istituto Romagnolo Per Lo Studio Dei Tumori Dino Amadori Irst S.r.l. Irccs

This study tests a new way to give radiation therapy to people with malignant pleural mesothelioma, a rare and serious lung cancer. The treatment uses a special machine called Tomotherapy to deliver high doses of radiation over just 5 days. The goal is to see if this short, inten…

This phase 2 trial is testing a radioactive drug called 177Lu-PSMA in 83 people with advanced or metastatic cancers that show up on a PSMA PET scan. The drug is given intravenously every 8 weeks for up to 4 cycles. The main goals are to check safety and see if the treatment can c…